fenofibric acid (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the fenofibric acid drug offered from Actavis Pharma, Inc.. This Peroxisome Proliferator Receptor alpha Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
NON-PROPRIETARY NAME: | fenofibric acid |
SUBSTANCE NAME: | FENOFIBRIC ACID |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Peroxisome Proliferator Receptor alpha Agonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE, DELAYED RELEASE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2016-01-21 |
END MARKETING DATE: | 0000-00-00 |
fenofibric acid HUMAN PRESCRIPTION DRUG Details:
Item Description | fenofibric acid from Actavis Pharma, Inc. |
LABELER NAME: | Actavis Pharma, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 45(mg/1) |
START MARKETING DATE: | 2016-01-21 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0228-2838_61552b7b-83cf-46d4-bf3d-e9d40e5d4371 |
PRODUCT NDC: | 0228-2838 |
APPLICATION NUMBER: | ANDA200920 |
Other FENOFIBRIC ACID Pharmaceutical Manufacturers / Labelers: